| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. | CEO and President, Director | Non-Qualified Stock Option (right to buy) | 375K | Mar 10, 2022 | Direct | ||
| FEMASYS INC | Director | Stock Option (Right to Buy) | 17K | Jun 14, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| FEMY | FEMASYS INC | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
| FEMY | FEMASYS INC | Jun 14, 2023 | 0 | $0 | 3 | Jun 16, 2023 | Director |
| AQST | Aquestive Therapeutics, Inc. | Mar 10, 2022 | 1 | $0 | 4 | Mar 14, 2022 | CEO and President, Director |
| AQST | Aquestive Therapeutics, Inc. | Aug 26, 2021 | 2 | $0 | 4 | Aug 27, 2021 | CEO and President, Director |